MUMBAI, India, June 13 -- Intellectual Property India has published a patent application (202517051817 A) filed by Philochem Ag, Otelfingen, Switzerland, on May 29, for 'carbonic anhydrase ix ligands for targeted delivery applications.'
Inventor(s) include Bassi, Gabriele; Cazzamalli, Samuele; Favalli, Nicholas; Mueller, Marco; Oehler, Sebastian; and Neri, Dario.
The application for the patent was published on June 13, under issue no. 24/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to protein ligands against Carbonic Anhydrase IX (CAIX) as target of biomedical relevance. In particular, the highly specific ligands may be able to exclusively interact with antigens expressed on the surface of tumor cells, namely, CAIX, sparing anti-target expressing healthy organs, thus enabling efficient in vivo pharmaco-delivery applications. The ligands may exhibit a particularly low dissociation constant and/or enzyme isoform specificity, and may be suitable for targeted delivery of a payload, such as a therapeutic and/or diagnostic agent, to a site afflicted by or at risk of disease or disorder characterized by expression of CAIX."
The patent application was internationally filed on Nov. 02, 2023, under International application No.PCT/EP2023/080619.
Disclaimer: Curated by HT Syndication.
